REPORTS

Let’s Pullulate and Expand Your Business

Global Urological Cancer Therapeutics Drugs Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 15, 2020  |  166 PAGES  |  REPORT CODE: CMM373423
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Urological Cancer Therapeutics Drugs is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.1% during the forecast period. The research provides insights for the global Urological Cancer Therapeutics Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Urological Cancer Therapeutics Drugs industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Urological Cancer Therapeutics Drugs Market Segmentations:

By Players:

  • Novartis

  • Pfizer

  • Johnson & Johnson

  • AstraZeneca

  • Astellas

  • Bristol-Myers Squibb

  • Abbott Laboratories

  • Celgene Corporation

  • Dendreon Corporation

  • Ferring Pharmaceuticals

  • GlaxoSmithKline plc

  • Indevus Pharmaceuticals Inc

  • Ipsen

  • Roche Healthcare

  • Sanofi SA

By Types:

  • Xofigo (radium Ra 223 dichloride)

  • Jevtana (cabazitaxel)

  • Inlyta (axitinib)

  • Votrient (pazopanib hydrochloride)

  • Sutent (sunitinib malate)

  • Zytiga (abiraterone acetate)

  • Xtandi (enzalutamide)

  • Opdivo (nivolumab)

  • Provenge (sipuleucel-T)

By End-User:

  • Hospital

  • Medical Research Laboratory

  • Others

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Urological Cancer Therapeutics Drugs Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Xofigo (radium Ra 223 dichloride) from 2014 to 2026

    • 1.3.2 Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Jevtana (cabazitaxel) from 2014 to 2026

    • 1.3.3 Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Inlyta (axitinib) from 2014 to 2026

    • 1.3.4 Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Votrient (pazopanib hydrochloride) from 2014 to 2026

    • 1.3.5 Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Sutent (sunitinib malate) from 2014 to 2026

    • 1.3.6 Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Zytiga (abiraterone acetate) from 2014 to 2026

    • 1.3.7 Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Xtandi (enzalutamide) from 2014 to 2026

    • 1.3.8 Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Opdivo (nivolumab) from 2014 to 2026

    • 1.3.9 Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Provenge (sipuleucel-T) from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.2 Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Medical Research Laboratory from 2014 to 2026

    • 1.4.3 Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Others from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Urological Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Urological Cancer Therapeutics Drugs Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Urological Cancer Therapeutics Drugs by Major Types

    • 3.4.1 Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Xofigo (radium Ra 223 dichloride)

    • 3.4.2 Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Jevtana (cabazitaxel)

    • 3.4.3 Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Inlyta (axitinib)

    • 3.4.4 Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Votrient (pazopanib hydrochloride)

    • 3.4.5 Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Sutent (sunitinib malate)

    • 3.4.6 Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Zytiga (abiraterone acetate)

    • 3.4.7 Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Xtandi (enzalutamide)

    • 3.4.8 Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Opdivo (nivolumab)

    • 3.4.9 Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Provenge (sipuleucel-T)

4 Segmentation of Urological Cancer Therapeutics Drugs Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Urological Cancer Therapeutics Drugs by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Urological Cancer Therapeutics Drugs in Hospital

    • 4.4.2 Market Size and Growth Rate of Urological Cancer Therapeutics Drugs in Medical Research Laboratory

    • 4.4.3 Market Size and Growth Rate of Urological Cancer Therapeutics Drugs in Others

5 Market Analysis by Major Regions

  • 5.1 Global Urological Cancer Therapeutics Drugs Production Analysis by Major Regions

  • 5.2 Global Urological Cancer Therapeutics Drugs Consumption Analysis by Major Regions

  • 5.3 Global Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis

6 Product Commodity of Urological Cancer Therapeutics Drugs Market in Major Countries

  • 6.1 Top 5 Export Countries in Urological Cancer Therapeutics Drugs market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Urological Cancer Therapeutics Drugs market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Urological Cancer Therapeutics Drugs market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Urological Cancer Therapeutics Drugs market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Urological Cancer Therapeutics Drugs market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Urological Cancer Therapeutics Drugs market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Urological Cancer Therapeutics Drugs Landscape Analysis

  • 7.1 North America Urological Cancer Therapeutics Drugs Landscape Analysis by Major Types

  • 7.2 North America Urological Cancer Therapeutics Drugs Landscape Analysis by Major End-Users

  • 7.3 North America Urological Cancer Therapeutics Drugs Landscape Analysis by Major Countries

    • 7.3.1 United States Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 7.3.2 Canada Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 7.3.3 Mexico Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

8 Europe Urological Cancer Therapeutics Drugs Landscape Analysis

  • 8.1 Europe Urological Cancer Therapeutics Drugs Landscape Analysis by Major Types

  • 8.2 Europe Urological Cancer Therapeutics Drugs Landscape Analysis by Major End-Users

  • 8.3 Europe Urological Cancer Therapeutics Drugs Landscape Analysis by Major Countries

    • 8.3.1 Germany Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 8.3.2 UK Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 8.3.3 France Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 8.3.4 Italy Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 8.3.6 Spain Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 8.3.7 Belgium Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 8.3.8 Poland Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 8.3.9 Russia Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 8.3.10 Turkey Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

9 Asia Pacific Urological Cancer Therapeutics Drugs Landscape Analysis

  • 9.1 Asia Pacific Urological Cancer Therapeutics Drugs Landscape Analysis by Major Types

  • 9.2 Asia Pacific Urological Cancer Therapeutics Drugs Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Urological Cancer Therapeutics Drugs Landscape Analysis by Major Countries

    • 9.3.1 China Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 9.3.2 Japan Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 9.3.4 India Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 9.3.6 South Korea Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

10 Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 10.3.2 Brazil Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 10.3.3 Nigeria Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

    • 10.3.4 South Africa Urological Cancer Therapeutics Drugs Market Volume and Growth Rate 

    • 10.3.5 Argentina Urological Cancer Therapeutics Drugs Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Novartis

    • 11.1.1 Novartis Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Pfizer

    • 11.2.1 Pfizer Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Johnson & Johnson

    • 11.3.1 Johnson & Johnson Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 AstraZeneca

    • 11.4.1 AstraZeneca Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Astellas

    • 11.5.1 Astellas Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Bristol-Myers Squibb

    • 11.6.1 Bristol-Myers Squibb Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Abbott Laboratories

    • 11.7.1 Abbott Laboratories Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Celgene Corporation

    • 11.8.1 Celgene Corporation Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Dendreon Corporation

    • 11.9.1 Dendreon Corporation Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Ferring Pharmaceuticals

    • 11.10.1 Ferring Pharmaceuticals Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 GlaxoSmithKline plc

    • 11.11.1 GlaxoSmithKline plc Company Profile and Recent Development

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Indevus Pharmaceuticals Inc

    • 11.12.1 Indevus Pharmaceuticals Inc Company Profile and Recent Development

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 Ipsen

    • 11.13.1 Ipsen Company Profile and Recent Development

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Roche Healthcare

    • 11.14.1 Roche Healthcare Company Profile and Recent Development

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 Sanofi SA

    • 11.15.1 Sanofi SA Company Profile and Recent Development

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 91 Figures and 133 Tables)

  • Figure Product Picture

  • Figure Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Xofigo (radium Ra 223 dichloride) from 2014 to 2026

  • Figure Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Jevtana (cabazitaxel) from 2014 to 2026

  • Figure Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Inlyta (axitinib) from 2014 to 2026

  • Figure Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Votrient (pazopanib hydrochloride) from 2014 to 2026

  • Figure Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Sutent (sunitinib malate) from 2014 to 2026

  • Figure Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Zytiga (abiraterone acetate) from 2014 to 2026

  • Figure Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Xtandi (enzalutamide) from 2014 to 2026

  • Figure Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Opdivo (nivolumab) from 2014 to 2026

  • Figure Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Provenge (sipuleucel-T) from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Hospital from 2014 to 2026

  • Figure Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Medical Research Laboratory from 2014 to 2026

  • Figure Global Urological Cancer Therapeutics Drugs Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Urological Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Urological Cancer Therapeutics Drugs Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Urological Cancer Therapeutics Drugs

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Urological Cancer Therapeutics Drugs by Different Types from 2014 to 2026

  • Table Consumption Share of Urological Cancer Therapeutics Drugs by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Xofigo (radium Ra 223 dichloride)

  • Figure Market Size and Growth Rate of Jevtana (cabazitaxel)

  • Figure Market Size and Growth Rate of Inlyta (axitinib)

  • Figure Market Size and Growth Rate of Votrient (pazopanib hydrochloride)

  • Figure Market Size and Growth Rate of Sutent (sunitinib malate)

  • Figure Market Size and Growth Rate of Zytiga (abiraterone acetate)

  • Figure Market Size and Growth Rate of Xtandi (enzalutamide)

  • Figure Market Size and Growth Rate of Opdivo (nivolumab)

  • Figure Market Size and Growth Rate of Provenge (sipuleucel-T)

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Urological Cancer Therapeutics Drugs by Different End-Users from 2014 to 2026

  • Table Consumption Share of Urological Cancer Therapeutics Drugs by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Hospital

  • Figure Market Size and Growth Rate of Medical Research Laboratory

  • Figure Market Size and Growth Rate of Others

  • Table Global Urological Cancer Therapeutics Drugs Production by Major Regions

  • Table Global Urological Cancer Therapeutics Drugs Production Share by Major Regions

  • Figure Global Urological Cancer Therapeutics Drugs Production Share by Major Regions in 2014

  • Figure Global Urological Cancer Therapeutics Drugs Production Share by Major Regions in 2018

  • Figure Global Urological Cancer Therapeutics Drugs Production Share by Major Regions in 2026

  • Table Global Urological Cancer Therapeutics Drugs Consumption by Major Regions

  • Table Global Urological Cancer Therapeutics Drugs Consumption Share by Major Regions

  • Figure Global Urological Cancer Therapeutics Drugs Consumption Share by Major Regions in 2014

  • Figure Global Urological Cancer Therapeutics Drugs Consumption Share by Major Regions in 2018

  • Figure Global Urological Cancer Therapeutics Drugs Consumption Share by Major Regions in 2026

  • Table North America Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis

  • Table Europe Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Urological Cancer Therapeutics Drugs market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Urological Cancer Therapeutics Drugs market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Urological Cancer Therapeutics Drugs market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Urological Cancer Therapeutics Drugs market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Urological Cancer Therapeutics Drugs Consumption by Types from 2014 to 2026

  • Table North America Urological Cancer Therapeutics Drugs Consumption Share by Types from 2014 to 2026

  • Figure North America Urological Cancer Therapeutics Drugs Consumption Share by Types in 2014

  • Figure North America Urological Cancer Therapeutics Drugs Consumption Share by Types in 2018

  • Figure North America Urological Cancer Therapeutics Drugs Consumption Share by Types in 2026

  • Table North America Urological Cancer Therapeutics Drugs Consumption by End-Users from 2014 to 2026

  • Table North America Urological Cancer Therapeutics Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure North America Urological Cancer Therapeutics Drugs Consumption Share by End-Users in 2014

  • Figure North America Urological Cancer Therapeutics Drugs Consumption Share by End-Users in 2018

  • Figure North America Urological Cancer Therapeutics Drugs Consumption Share by End-Users in 2026

  • Table North America Urological Cancer Therapeutics Drugs Consumption by Major Countries from 2014 to 2026

  • Table North America Urological Cancer Therapeutics Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Urological Cancer Therapeutics Drugs Consumption Share by Major Countries in 2014

  • Figure North America Urological Cancer Therapeutics Drugs Consumption Share by Major Countries in 2018

  • Figure North America Urological Cancer Therapeutics Drugs Consumption Share by Major Countries in 2026

  • Figure United States Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Urological Cancer Therapeutics Drugs Consumption by Types from 2014 to 2026

  • Table Europe Urological Cancer Therapeutics Drugs Consumption Share by Types from 2014 to 2026

  • Figure Europe Urological Cancer Therapeutics Drugs Consumption Share by Types in 2014

  • Figure Europe Urological Cancer Therapeutics Drugs Consumption Share by Types in 2018

  • Figure Europe Urological Cancer Therapeutics Drugs Consumption Share by Types in 2026

  • Table Europe Urological Cancer Therapeutics Drugs Consumption by End-Users from 2014 to 2026

  • Table Europe Urological Cancer Therapeutics Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Urological Cancer Therapeutics Drugs Consumption Share by End-Users in 2014

  • Figure Europe Urological Cancer Therapeutics Drugs Consumption Share by End-Users in 2018

  • Figure Europe Urological Cancer Therapeutics Drugs Consumption Share by End-Users in 2026

  • Table Europe Urological Cancer Therapeutics Drugs Consumption by Major Countries from 2014 to 2026

  • Table Europe Urological Cancer Therapeutics Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Urological Cancer Therapeutics Drugs Consumption Share by Major Countries in 2014

  • Figure Europe Urological Cancer Therapeutics Drugs Consumption Share by Major Countries in 2018

  • Figure Europe Urological Cancer Therapeutics Drugs Consumption Share by Major Countries in 2026

  • Figure Germany Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure France Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Urological Cancer Therapeutics Drugs Consumption by Types from 2014 to 2026

  • Table Asia Pacific Urological Cancer Therapeutics Drugs Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Urological Cancer Therapeutics Drugs Consumption Share by Types in 2014

  • Figure Asia Pacific Urological Cancer Therapeutics Drugs Consumption Share by Types in 2018

  • Figure Asia Pacific Urological Cancer Therapeutics Drugs Consumption Share by Types in 2026

  • Table Asia Pacific Urological Cancer Therapeutics Drugs Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Urological Cancer Therapeutics Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Urological Cancer Therapeutics Drugs Consumption Share by End-Users in 2014

  • Figure Asia Pacific Urological Cancer Therapeutics Drugs Consumption Share by End-Users in 2018

  • Figure Asia Pacific Urological Cancer Therapeutics Drugs Consumption Share by End-Users in 2026

  • Table Asia Pacific Urological Cancer Therapeutics Drugs Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Urological Cancer Therapeutics Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Urological Cancer Therapeutics Drugs Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Urological Cancer Therapeutics Drugs Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Urological Cancer Therapeutics Drugs Consumption Share by Major Countries in 2026

  • Figure China Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandUrological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure India Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Urological Cancer Therapeutics Drugs Consumption Share by Major Countries in 2026

  • Figure GCC Countries Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Urological Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Novartis

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

  • Figure Sales and Growth Rate Analysis of Novartis

  • Figure Revenue and Market Share Analysis of Novartis

  • Table Product and Service Introduction of Novartis

  • Table Company Profile and Development Status of Pfizer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

  • Figure Sales and Growth Rate Analysis of Pfizer

  • Figure Revenue and Market Share Analysis of Pfizer

  • Table Product and Service Introduction of Pfizer

  • Table Company Profile and Development Status of Johnson & Johnson

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

  • Figure Sales and Growth Rate Analysis of Johnson & Johnson

  • Figure Revenue and Market Share Analysis of Johnson & Johnson

  • Table Product and Service Introduction of Johnson & Johnson

  • Table Company Profile and Development Status of AstraZeneca

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

  • Figure Sales and Growth Rate Analysis of AstraZeneca

  • Figure Revenue and Market Share Analysis of AstraZeneca

  • Table Product and Service Introduction of AstraZeneca

  • Table Company Profile and Development Status of Astellas

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas

  • Figure Sales and Growth Rate Analysis of Astellas

  • Figure Revenue and Market Share Analysis of Astellas

  • Table Product and Service Introduction of Astellas

  • Table Company Profile and Development Status of Bristol-Myers Squibb

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

  • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

  • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

  • Table Product and Service Introduction of Bristol-Myers Squibb

  • Table Company Profile and Development Status of Abbott Laboratories

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

  • Figure Sales and Growth Rate Analysis of Abbott Laboratories

  • Figure Revenue and Market Share Analysis of Abbott Laboratories

  • Table Product and Service Introduction of Abbott Laboratories

  • Table Company Profile and Development Status of Celgene Corporation

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation

  • Figure Sales and Growth Rate Analysis of Celgene Corporation

  • Figure Revenue and Market Share Analysis of Celgene Corporation

  • Table Product and Service Introduction of Celgene Corporation

  • Table Company Profile and Development Status of Dendreon Corporation

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dendreon Corporation

  • Figure Sales and Growth Rate Analysis of Dendreon Corporation

  • Figure Revenue and Market Share Analysis of Dendreon Corporation

  • Table Product and Service Introduction of Dendreon Corporation

  • Table Company Profile and Development Status of Ferring Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Ferring Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Ferring Pharmaceuticals

  • Table Product and Service Introduction of Ferring Pharmaceuticals

  • Table Company Profile and Development Status of GlaxoSmithKline plc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc

  • Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc

  • Figure Revenue and Market Share Analysis of GlaxoSmithKline plc

  • Table Product and Service Introduction of GlaxoSmithKline plc

  • Table Company Profile and Development Status of Indevus Pharmaceuticals Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Indevus Pharmaceuticals Inc

  • Figure Sales and Growth Rate Analysis of Indevus Pharmaceuticals Inc

  • Figure Revenue and Market Share Analysis of Indevus Pharmaceuticals Inc

  • Table Product and Service Introduction of Indevus Pharmaceuticals Inc

  • Table Company Profile and Development Status of Ipsen

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ipsen

  • Figure Sales and Growth Rate Analysis of Ipsen

  • Figure Revenue and Market Share Analysis of Ipsen

  • Table Product and Service Introduction of Ipsen

  • Table Company Profile and Development Status of Roche Healthcare

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Healthcare

  • Figure Sales and Growth Rate Analysis of Roche Healthcare

  • Figure Revenue and Market Share Analysis of Roche Healthcare

  • Table Product and Service Introduction of Roche Healthcare

  • Table Company Profile and Development Status of Sanofi SA

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi SA

  • Figure Sales and Growth Rate Analysis of Sanofi SA

  • Figure Revenue and Market Share Analysis of Sanofi SA

  • Table Product and Service Introduction of Sanofi SA


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top